Objective Cerebrovascular disease (CVD) is a serious complication of acute leukemia, and the underlying conditions are different from the commonrisk factors for CVD. The aim of this study was to characterize the clinical and pathological features of CVDin patients with acute leukemia.
Introduction
Cerebrovascular disease (CVD)is a serious complication of leukemia (1, 2) as well as bleeding or thrombosis in other organs of the body (3) . A representative cause of CVDin those patients is abnormal coagulation or coagulopathy such as disseminated intravascular coagulation (DIC) (1, 2, 4, 5) . Therefore, hematologists have developed supportive therapies for coagulopathy associated with leukemia. However, in spite of these therapies, we had 14 CVDpatients in a series of 116 autopsied cases of adult acute leukemia. This indicates that CVDis still frequent in leukemia patients whoundergo advanced therapies for coagulopathy. Previous studies of leukemia patients have shown that CVD is due to unusual causes (2, 4, 5) . One example is cerebral infarction due to fungal embolism (2, 4) . Accordingly, several pathological conditions other than coagulopathy could also play significant roles in the pathogenesis of CVDin leukemia patients. To clarify the causes of CVDin acute leukemia, we examined 14 CVD patients with acute leukemia both neuropathologically and clinically. Our results showed that at least three groups of CVDcould be defined by their pathogenesis and by their underlying hematological conditions. For editorial comment, see p 1081.
Subjects and Methods
During the period between January 1978 and December 1998, there were 1 16 autopsied cases of adult acute leukemia in the autopsy registry at Yamagata University School of Medicine. Using the clinical record registry system, we identifiedNeuropathological examination of the 14 brains was done both macroscopically and microscopically. Representative sections of the brains were processed for 6-|im thick paraffin sections and stained with hematoxylin-eosin and luxol fast blue stains. Whenappropriate, stains for microorganisms including Gram's, periodic acid-Schiff (PAS) and Grocott were applied. Blood vessels were examined with elastica Masson-Goldner stain.
Clinicopathological correlation of the 14 patients was made by review of clinical records including neuroradiological studies with CT scan or MRimaging. Commonrisk factors for CVDsuch as hypertension and hyperlipidemia were checked in all of the patients. General autopsy records were also reviewed to obtain information on any underlying pathological conditions possibly related to the pathogenesis of CVD.
Results
The 14 cases included in this study are summarized in Table1. Wehave divided those cases into four groups as defined by neuropathological findings.
General features
Thepatients consisted of 6 menand 8 women and the age of onset of CVDranged from 17 to 83 (mean 55) years. Twelve patients had CVDduring the course of standard antileukemic chemotherapy, but in two patients (cases 7 and 8), CVDhad occurred before the chemotherapywas started. There was no patient whounderwent bone marrowtransplantation. Noneurological presentations correlated with the different types of 
General autopsy findings
All the patients in this group had hypoplastic bone marrow, consistent with bone marrowsuppression due to chemotherapy. The lungs were infected with aspergillus or mucormyces. In all patients, the fungi were the same as those noted in the brain lesions. The thyroid gland, spleen and liver also showed dissemination of those fungi. There was no evidence of endocarditis.
Clinical analysis
Reviewof clinical records revealed that the patients in this group had an extremely reduced number of peripheral white blood cells or agranulocytosis (WBCcount <500/|jl or granulocyte count< 100/|il). Pneumonia, which was not improved by anti-bacterial and anti-fungal therapies, was another common feature of those patients. All the patients were in a bone marrow suppressive state due to antileukemic chemotherapyat the onset of CVD.Because four cases (cases 1, 3, 4 and 5) were remission induction failure and one (case 2) was a relapsed case, salvage chemotherapies had been administrated, which resulted in severe and prolonged agranulocytosis. Twopatients were examined with CTscan and diagnosed as having hemor- 2) Multiple cerebral hemorrhages around leukemic cell nodules (cases 6 and 7)
Neu ropa tho logy Twocases showedmacroscopic multiple cerebral hemorrhages. Each hemorrhagic lesion was generally round in shape and up to 2 cm in diameter. The lesions were located in the subcortical white matter and basal ganglia of the cerebrum. Microscopically, the hemorrhagic lesions consisted of leukemic cell nodules surrounded by numerous red blood cells, forming hemorrhagic lesions. There was no leptomeningeal leukemic cell infiltration.
General autopsy findings
The bone marrow showed proliferation of leukemic cells. Leukemic cells also invaded the spleen, lungs, lymph nodes and myocardium. Unlike the brain, leukemic cell infiltration into the organs of the body was not surrounded by the red blood cell layer.
Clinical analysis
Review of clinical records revealed a marked increase in leukemic cells in the peripheral blood (WBCcount >100, 000/ \\X) at the onset of cerebral hemorrhage. This abnormal hematological condition occurred a few days after (case 6) or before (case 7) the antileukemic chemotherapy was started. Brain CT scan of the patients showed multiple cerebral hemorrhages. Amongthe various clinical findings, marked leukocytosis was characteristic in this group of patients.
3) Cerebral hemorrhage due to coagulopathy (cases 8 to 1 1)
Neu ropathology
Patients of this group suffered a single massive hemorrhage (cases 8, 10 and ll) as well as numerous tiny hemorrhagic foci in various regions of the brain. One case (case 9) had subdural hematomain addition to the pontine hemorrhage. Microscopic examination of the brain did not show any microorganisms, leukemic cell infiltration nor vascular alterations. Because of multiple hemorrhagic lesions and exclusion of other causes, those four autopsy cases were diagnosed as having cerebral hemorrhage due to coagulopathy.
General autopsy findings
Macro-and micro-scopic hemorrhagic foci were noted in various organs of the body. Intestinal bleeding from mucosal hemorrhagic lesions was a representative finding. Onecase (case 9) had a hematoma in the mediastinum.
Clinical analysis
Bleeding tendency was a commonclinical feature in those patients; skin purpura and oral or nasal bleeding were observed.
Bleeding tendency was due to thrombocytopenia (case 8) or DIC (cases 9, 10 and ll). The patients with DIC had acute promyelocytic leukemia as an underlying disease. One patient (case 9) was treated with all-retinoic acid (ATRA), but had the pontine hemorrhage and subdural hematoma before the reduction of leukemic cells and resolution of DIC. Twocases (case 10 and ll) had relapsed acute promyelocytic leukemia, and had been treated with salvage chemotherapy. One case (case 9) was examined with MRimaging, which showed a concurrence of pontine hemorrhage and subdural hematoma.
4) Cerebrovascular disease due to miscellaneous causes (cases 12 to 14)
There were three patients in this group who had no pathological condition related to acute leukemia. A 63-year-old man (case 12) did not have any specific neuropathological changes that could explain the cause of his subdural hematoma. A 69-year-old woman(case 1 3) had several episodes of cerebral hemorrhage before and during the course of acute leukemia. Neuropathological examination revealed cerebral amyloid angiopathy, which was likely to be the cause of her recurrent brain hemorrhages. An 83-year-old man (case 14) suffered an acute subdural hematoma after he fell and hit his head on the floor.
Discussion
Our study demonstrated that at least three types of CVD could be identified, and they were associated with specific clinical and neuropathological features in leukemia patients (Table   2 ). Hemorrhagic cerebral infarction was caused by fungal embolism resulting from agranulocytosis induced by antileukemic chemotherapy. Multiple cerebral hemorrhages occurred due to leukemic cell infiltration under an extremely increased number of leukemic cells. A single massive cerebral hemorrhage was associated with coagulopathy, especially DIC. Five cases of hemorrhagic infarction constitute a distinct group among the leukemia patients with CVDin that its etiology is fungal embolism (2, 7). Regardless of the subtypes of acute leukemia, the underlying condition in those patients was bone marrowsuppression and subsequent agranulocytosis during or after antileukemic therapy. Agranulocytosis can induce fungal hyphae dissemination from the lung (pneumonia) to the brain, resulting in fungal emboli, instead of abscess (8) or granuloma (9) formation. Disseminated fungal infection often causes hemorrhagic infarction in neutropenic leukemia patients (2, 7, 8) , although hemorrhagic infarction in leukemia patients could be diagnosed clinically as a result of abnormal coagulation ( 10) . Fungal infection frequently complicates acute leukemia ( 1 1 ).
The causative microorganisms are generally Candida, and sometimes aspergillus or mucormyces (1 1). The question then arises as to why aspergillus and mucormycesand not Candida cause hemorrhagic infarction. According to Scaravilli and Cook ( 12) , there is a relationship between the size of fungal hyphae and the types of brain lesions. The large hyphae of aspergillus or mucormyceswould be trapped within the blood vessels of large to mediumsize, resulting in cerebral embolism. Onthe other hand, the smaller-sized pseudohyphae of Candida would be trapped in the preterminal blood vessels, causing multiple microscopic lesions, commonly called abscess. The above hypothesis supports our observation that patients with hemorrhagic infarction had occlusions of the medium-sized branches of the cerebral arteries.
Patients with multiple cerebral hemorrhages had marked leukocytosis as a commonclinical finding. The first case with such a clinicopathological entity was described by Freireich et al in 1960 (13) . To date, leukemic cell infiltration has been reported in patients with chronic leukemia in blastic crisis or acute monocytic leukemia (14) . In the present study, one case of acute myelogenous leukemia (case 6) and one case of acute lymphocytic leukemia (case 7) had the same pathology. Marked leukocytosis could be a more significant risk factor for multiple cerebral hemorrhages than the different types of leukemia.
At this moment,there was no definite explanation for the pathogenesis of cerebral hemorrhages around leukemic cell nodules. One explanation is based on the observation by Freireich et al (13) Coagulopathy caused a single massive hemorrhage in four out of 14 patients. A noteworthy finding is that three out of four patients (cases 9 to ll) in this group had acute promyelocytic leukemia (APL) with DIC. APL is frequently associated with DIC in the early stage of the disease (3). Therefore, in spite of the advanced supportive therapies against coagulopathy, APLis still an important risk factor for cerebral hemorrhage among the FABsubtypes of acute leukemia.
The new therapy with ATRAhas decreased the complications of coagulopathy as well as increased the rate of complete remission among APLpatients (15) . Accordingly, the use of ATRAcould decrease the risk of cerebral hemorrhage in pa-tients with APL. In the present study, we could not conclude whether there is a decrease in frequency of cerebral hemorrhage associated with APLbecause the number of our autopsy cases was too few (cases 9 to ll).
In conclusion, this study can provide clues to identify the causes of CVDin leukemia patients (Table 2 ). In the case of a leukemia patient diagnosed as having CVDby either CT scan or MRimaging of the brain, hemorrhagic infarction associated with agranulocytosis and pneumonia would be due to aspergillosis or mucormycosis. Multiple hemorrhages associated with marked leukocyotsis would be a sign of leukemic cell infiltration.
A single massive hemorrhage could be associated with coagulopathy, usually resulting from DIC complicated with APL. Another implication of the present study is that the causes and types of CVDin leukemia patients (Table 2 ) depend largely on the therapeutic modalities. A review of literature and the results of our study showchanges in the predominant causes and types of CVDalong with improved therapeutic innovation. Preceding the introduction of effective chemotherapeutic agents, multiple cerebral hemorrhagedue to leukemic cell infiltration was reported (13) . At present, such patients seem to be exceptional cases whowere not responsive to remission induction therapy. Around the 1990s, the introduction of effective chemotherapeutic regimens improvedthe remis sion rate of acute leukemia patients, but it also increased the rate of severe agranulocytosis. Cases of hemorrhagic infarction due to fungal infection occurred at a time whenthere were no effective antifungal agents (7) (8) (9) 12) . In our autopsy series, there were no patients with hemorrhagic infarction after the wide use of the antifungal agents commenced.CVDdue to DIC in APLpatients (2, 3) could decrease in number with the use of ATRAinstead of conventional chemotherapy (15) . In the future, CVDwith unexpected pathomechanisms could occur in patients with acute leukemia due to the newly introduced therapies. Cerebral hemorrhage associated with the use of cyclosporin-A/FK506after bone marrowtransplantation seems to be such an example (16) .
